Emergent BioSolutions Inc

Emergent BioSolutions to Release Third Quarter 2021 Financial Results and Conduct a Conference Call on November 4, 2021

18 Oct 2021 06:30:00 By Nasdaq GlobeNewswire

Emergent BioSolutions Announces Initiation of Pivotal Phase 3 Study Evaluating the Safety and Immunogenicity of Its Single-Dose Chikungunya Vaccine Candidate, CHIKV VLP

15 Oct 2021 06:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: Emergent BioSolutions Inc

01 Oct 2021 09:45:03 By NetDania Notify

NetDania - New 12 months Low: Emergent BioSolutions Inc

30 Sep 2021 11:15:15 By NetDania Notify

NetDania - New 12 months Low: Emergent BioSolutions Inc

29 Sep 2021 15:19:24 By NetDania Notify

NetDania - New 12 months Low: Emergent BioSolutions Inc

28 Sep 2021 10:50:49 By NetDania Notify

NetDania - New 12 months Low: Emergent BioSolutions Inc

27 Sep 2021 09:45:10 By NetDania Notify

NetDania - New 12 months Low: Emergent BioSolutions Inc

24 Sep 2021 12:07:17 By NetDania Notify

NetDania - New 12 months Low: Emergent BioSolutions Inc

23 Sep 2021 12:01:16 By NetDania Notify

NetDania - New 12 months Low: Emergent BioSolutions Inc

21 Sep 2021 11:35:53 By NetDania Notify

Emergent BioSolutions Secures Multi-Year Development and Manufacturing Agreement with Providence Therapeutics for its mRNA COVID-19 Vaccine Candidate, PTX-COVID19-B

14 Sep 2021 08:00:02 By Nasdaq GlobeNewswire

Emergent BioSolutions’ COVID-19 Human Immune Globulin Product Candidate to be Evaluated in NIH-Sponsored Phase 3 Clinical Trial (INSIGHT-012) of Hyperimmune Intravenous Immunoglobulin for Outpatient Treatment of COVID-19

25 Aug 2021 06:30:00 By Nasdaq GlobeNewswire

Emergent BioSolutions to Participate in Investor Conferences

23 Aug 2021 16:05:00 By Nasdaq GlobeNewswire

Emergent BioSolutions Reports Financial Results For Second Quarter 2021

29 Jul 2021 16:05:01 By Nasdaq GlobeNewswire

Emergent BioSolutions to Resume Manufacturing Covid-19 Vaccine at Bayview Facility

29 Jul 2021 07:24:59 By Nasdaq GlobeNewswire

Reverse the Silence Campaign Casts a National Spotlight on Overdose Risks Associated with Opioid Use

26 Jul 2021 09:01:00 By Nasdaq GlobeNewswire

Emergent BioSolutions to Release Second Quarter 2021 Financial Results and Conduct a Conference Call on July 29, 2021

15 Jul 2021 06:30:00 By Nasdaq GlobeNewswire

COVID-19 Vaccine Drug Substance Manufactured by Emergent BioSolutions Authorized as Part of Johnson & Johnson’s Emergency Use Authorization

11 Jun 2021 16:35:24 By Nasdaq GlobeNewswire

Emergent BioSolutions Announces Positive Two-Year Persistence Data From Phase 2 Study Evaluating CHIKV VLP, the Company’s Chikungunya Virus Virus-Like Particle Vaccine Candidate

26 May 2021 06:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: Emergent BioSolutions Inc

11 May 2021 09:45:06 By NetDania Notify